Search

Your search keyword '"Peytavin, G."' showing total 557 results

Search Constraints

Start Over You searched for: Author "Peytavin, G." Remove constraint Author: "Peytavin, G." Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
557 results on '"Peytavin, G."'

Search Results

1. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

2. Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen.

3. Impact of Human Immunodeficiency Virus Type 1 Minority Variants on the Virus Response to a Rilpivirine-Based First-line Regimen

4. Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

6. Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients

7. Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma

8. Depressive symptoms after hepatitis C cure and socio-behavioral correlates in aging people living with HIV (ANRS CO13 HEPAVIH)

10. Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study

11. Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial)

12. Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course

13. Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study

18. HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007–12: impact on susceptibility to first-line strategies

19. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity

21. Virological failure of patients on maraviroc-based antiretroviral therapy

22. Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy

25. Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study

28. National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001–2011

32. HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes

34. Cellular HIV-1 DNA quantification and short-term and long-term response to antiretroviral therapy

44. Infections II

50. Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.

Catalog

Books, media, physical & digital resources